Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) --...
Staff
Skylight Health Names Paul Kulas Senior Vice President of Operations
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG ; OTCQX:SHGFF) (“Skylight Health” or the “Company”), announced...
Microbix Announces Material First Sales of Viral Transport Medium
Initial Production of 50,000 Vials Entirely SoldMISSISSAUGA, Ontario, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB:...
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic Fibrosis
Publication titled: “Targeting G542X CFTR Nonsense Alleles With ELX-02 Restores CFTR Function in Human-Derived Intestinal Organoids”WALTHAM, Mass., Feb. 09, 2021...
Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020
- Company had $81 million of cash and cash equivalents as of December 31, 2020, and expects to receive additional...
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
All eight patients treated with OTL-203 show stable cognitive function, motor function and growth within the normal range at multiple...
MEDIA ADVISORY: Wear red for women’s heart health: National day of awareness February 13
Heart disease is still the number one killer of women, yet women are under-studied, under-treated, underdiagnosed, and under-aware when it...
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections
Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx...
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
LAVAL, Quebec, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST)...
Notice to the Annual General Meeting of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO ANNUAL GENERAL MEETING 9 FEBRUARY 2021 at 12:15 EET Notice to the...
InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States
TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention...
Philips successfully completes tender offer for BioTelemetry, Inc.
February 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today...
gaitQ Provides Business Update
gaitQ Provides Business Update Recent fundraising to support early testing of Parkinson’s system in a clinical studySupport received from Parkinson’s...
Orion Group Financial Statement Release for 2020
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2020 9 FEBRUARY 2021 at 12:00 Orion Group Financial Statement Release for 2020 This...
Relay Medical Announces Participation in Glow LifeTech RTO Financing
Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
Izotropic Unveils “Izoview” Branding for Breast CT Platform in Development and Files Trademark Applications
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing true...
NextGen Healthcare Powers 1 Million Telehealth Visits in 2020
Adoption of NextGen Virtual Visits™ Accelerated by COVID-19 Pandemic ATLANTA--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of...
Emanate Health Contact Tracing Dashboard Helps Track COVID-19 Patients to Prevent Staff Exposure Using MEDITECH Expanse EHR
WESTWOOD, Mass.--(BUSINESS WIRE)--Emanate Health (Covina, CA) recently partnered with MEDITECH Professional Services to develop disease investigation and contact tracing dashboards...
Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation
Minimally Invasive creates a new product category in breast aesthetics with a total addressable market of $4-5 billion Clinical study...
CLS Holdings USA, Inc. Reports Record January Revenues, Continues Growing Product Catalog
LAS VEGAS, NV / ACCESSWIRE / February 9, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'',...